Tirzepatide Peptide Powder CAS No. 2023788-19-2 for Laboratory Research Use
TDS 2101 Inquiries
2023788-19-2
Pharmaceutical Grade
99%
shenzhen
zhongshuan
vial /box /carton /bottle
2027-01-09
peptide
-
Product Details
-
Seller Information
-
Inquiry History
-
DescriptionECHEMI Editorial Reference
Tirzepatide (LY3298176) was developed as a dual agonist to both GLP-1 and gastric inhibitory polypeptide (GIP) receptors (Frias et al., 2018). Similar to GLP-1, GIP is an incretin hormone that functions to induce insulin secretion.
CertificatesBasic Info-
Product Name:
Tirzepatide
Other Name:LY3298176;
CAS No.:2023788-19-2
Molecular Formula:C225H348N48O68
Molecular Weight:4813
EC Number:200-001-8
Categories:
Characteristics-
Appearance:
White to off-white
Research-
Class:
Dual agonist — GIPR, GLP-1R
Status:FDA-approved (Mounjaro / Zepbound)
Mechanism:Dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. A 39-amino-acid modified peptide with a C20 fatty diacid moiety that enables albumin binding for extended half-life (~5 days). Selectively activates both GIPR and GLP-1R signaling pathways.
EC50 (Human GLP1R):0.934 nM
EC50 (Human GIPR):0.0224 nM
Source:Frias JP, et al. N Engl J Med. 2021;385(6):503-515.DOI
Clinical Development:NCT03954834; NCT03987919; NCT03882970; NCT03730662; NCT04039503
FDA:Mounjaro, Zepbound (approved 2022-05-13)
References-
ChEMBL:DrugBank:KEGG DRUG:PubChem:Disclaimer:
Tirzepatide is approved as a prescription medicine (Mounjaro, Zepbound) in certain jurisdictions. This listing is for industrial and laboratory research use only. Research-chemical listings on B2B marketplaces are not interchangeable with approved medicines. Confirm CAS, specification, and regulatory pathway with the seller. It is not medical advice, a clinical recommendation, or an approved therapy description.
-
-
Seller Information
-
Business Type:
Trader
-
Main Products:
peptide
-
Location:
Room A0693, 6th Floor, Building 3, No.5 Lvtai Road, Zhongtai Subdistrict, Yuhang District, Hangzhou City, Zhejiang Province
-
Average lead Time:
15 days
-
Total Annual Revenue:
$1 million-$2.5 million
-
Total Employees:
51-100
-
Year of Establishment:
2025
Company Certificates-
TR60 COA
-
-
Inquiry History2101 Inquiries
Country Product Purchase Quantity Date Posted
Brazil
Tirzepatide
100 G Oct 28, 2026
Belgium
Tirzepatide
10 MG Oct 28, 2026
United States
tirzepatide
100 MG Oct 28, 2026
United States
Tirzepatide
60 MG Oct 28, 2026
United States
Tirzepatide
10 PCS Oct 28, 2026
United States
tirzepatide
30 MG Oct 27, 2026
United States
Tirzepatide
40 MG Oct 27, 2026
Philippines
Tirzepatide
2 MT Oct 27, 2026
Philippines
Tirzepatide
30 MG Oct 26, 2026
Slovakia
Tirzepatide
1 G Oct 26, 2026
France
Tirzepatide
1 KG Oct 25, 2026
United States
Tirzepatide
2.5 MG Oct 25, 2026
United Kingdom
Tirzepatide
5 MT Oct 25, 2026
United Kingdom
Tirzepatide
6 MT Oct 24, 2026
Peru
tirzepatide
10 MG Oct 21, 2026
Puerto Rico
tirzepatide
40 MG Oct 21, 2026
United States
Tirzepatide
10 MT Oct 21, 2026
South Africa
Tirzepatide
1 MT Oct 20, 2026
United States
Tirzepatide
5 KG Oct 20, 2026
United States
tirzepatide
30 MG Oct 20, 2026 Post an enquiry for this product
More from this Seller
-
-
-
99% Purity cartalax CAS 45234-02-4 Raw Peptide Factory Supply Quality with Good Price
Pharmaceutical Grade / 99%
$65-66/MT FOB
-
-
-
-
Snap8 10mg (CAS 868844-74-0) high quality and fast delivery China factory 99% purity
Pharmaceutical Grade / 99%
$3.5-4/BOU FOB
-
-
-
-
Cosmetic Hyaluronic Acid Powder Pharmlaceutica Raw Material Powder Peptide
Pharmaceutical Grade / 99%
$5/G FOB
-
-
-
-
Thymalin Customized Lyophilized Peptides CAS 79621-14-0 Thymalin Raw Powder Improve Cardiovascular System
Pharmaceutical Grade / 99%
$5/G FOB
-
-
-
-
Botulinum Toxin | CAS 93384-43-1 | 99% Purity Research & Cosmetic Grade Raw Powder
Pharmaceutical Grade / 99%
$9-10/BOU FOB
-
-
-
-
VIP 40077-57-4 99% purity High Quality Research Customizable peptides China factory
Pharmaceutical Grade / 99%
$7.5-8/BOU FOB
-

